首页> 外文OA文献 >Study of the transformations of micro/nano-crystalline acetaminophen polymorphs in drug-polymer binary mixtures
【2h】

Study of the transformations of micro/nano-crystalline acetaminophen polymorphs in drug-polymer binary mixtures

机译:药物 - 聚合物二元混合物中微/纳晶对乙酰氨基酚多晶型物的转化研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

This study elucidates the physical properties of sono-crystallised micro/nano-sized acetaminophen/paracetamol (PMOL) and monitors its possible transformation from polymorphic form I (monoclinic) to form II (orthorhombic). Hydrophilic Plasdone® S630 copovidone (S630), N-vinyl-2-pyrrolidone and vinyl acetate copolymer, and methacrylate-based cationic copolymer, Eudragit® EPO (EPO), were used as polymeric carriers to prepare drug/polymer binary mixtures. Commercially available PMOL was crystallised under ultra sound sonication to produce micro/nano-sized (0.2–10 microns) crystals in monoclinic form. Homogeneous binary blends of drug-polymer mixtures at various drug concentrations were obtained via a thorough mixing. The analysis conducted via the single X-ray crystallography determined the detailed structure of the crystallised PMOL in its monoclinic form. The solid state and the morphology analyses of the PMOL in the binary blends evaluated via differential scanning calorimetry (DSC), modulated temperature DSC (MTDSC), scanning electron microscopy (SEM) and hot stage microscopy (HSM) revealed the crystalline existence of the drug within the amorphous polymeric matrices. The application of temperature controlled X-ray diffraction (VTXRPD) to study the polymorphism of PMOL showed that the most stable form I (monoclinic) was altered to its less stable form II (orthorhombic) at high temperature (>112°C) in the binary blends regardless of the drug amount. Thus, VTXRD was used as a useful tool to monitor polymorphic transformations of crystalline drug (e.g. PMOL) to assess their thermal stability in terms of pharmaceutical product development and research.
机译:这项研究阐明了声结晶微/纳米对乙酰氨基酚/扑热息痛(PMOL)的物理性质,并监测了其从多晶型I(单斜晶)向晶型II(斜方晶)的可能转变。亲水性Plasdone®S630共聚维酮(S630),N-乙烯基-2-吡咯烷酮和乙酸乙烯酯共聚物以及基于甲基丙烯酸酯的阳离子共聚物Eudragit®EPO(EPO)被用作聚合物载体,以制备药物/聚合物二元混合物。市售的PMOL在超声处理下结晶,以单斜晶形式生产微米/纳米尺寸(0.2-10微米)的晶体。通过彻底混合获得各种药物浓度下的药物-聚合物混合物的均相二元共混物。通过单X射线晶体学进行的分析确定了单斜晶形式的结晶PMOL的详细结构。通过差示扫描量热法(DSC),调温DSC(MTDSC),扫描电子显微镜(SEM)和热台显微镜(HSM)对二元混合物中的PMOL进行了固态和形态分析,揭示了该药物的晶体存在在无定形聚合物基质中。应用温控X射线衍射(VTXRPD)研究PMOL的多态性表明,在高温(> 112°C)下,最稳定的晶型I(单斜晶)变成了较不稳定的晶型II(斜方晶)。二元共混物,与药物用量无关。因此,VTXRD可用作监测结晶药物(例如PMOL)的多态转化,以评估其在药品开发和研究中的热稳定性的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号